Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide

Autor: Nathalie Morel, Du Le Thi Huong Boutin, Véronique Le Guern, Jean-Emmanuel Kahn, Zahir Amoura, Jean-Charles Piette, Zeina Chakhtoura, Marie-Laure Tanguy, Jean-Marc Lacorte, Dominique Farge, Gaëlle Guettrot-Imbert, Aurélien Delluc, Damien Sène, Anne Bachelot, Philippe Touraine, Jean-Robert Harlé, Françoise Sarrot-Reynauld, Pascale Ghillani-Dalbin, Anne Gompel, Elisabeth Vidal, Lionel Galicier, Karim Sacre, Pierre Duhaut, Olivier Lambotte, Salim Trad, Jacques Pourrat, O. Aumaître, Nathalie Costedoat-Chalumeau, Camille Francès

Publikováno v: Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2013, 98 (9), pp.3785-92. 〈10.1210/jc.2013-1235〉
Journal of Clinical Endocrinology and Metabolism, 2013, 98 (9), pp.3785-92. ⟨10.1210/jc.2013-1235⟩
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2013, 98 (9), pp.3785-92. ⟨10.1210/jc.2013-1235⟩

Context: Cyclophosphamide is used for renal and major extrarenal involvement in systemic lupus erythematosus (SLE) and is associated with a risk of premature ovarian failure. There are no data available about the relation between anti-Müllerian horm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f74f8b5df754cd4d28d00dcee669dcb
http://hal.univ-brest.fr/hal-00935382

Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3)

Autor: Beckmann, L., Hüsing, A., Setiawan, V. W., Amiano, P., Clavel-Chapelon, F., Chanock, S. J., Cox, D. G., Diver, R., Dossus, L., Feigelson, H. S., Haiman, C., Hallmans, G., Hayes, R. B., Henderson, B. E., Hoover, R. N., Hunter, D. J., Khaw, K., Kolonel, L. N., Kraft, P., Lund, E., Le Marchand, L., Peeters, P. H. M., Riboli, E., Stram, D., Thomas, G., Thun, M. J., Tumino, R., Trichopoulos, D., Vogel, U., Willett, W. C., Yeager, M., Ziegler, R., Hankinson, S. E., Kaaks, R., Renseigné, Non

Publikováno v: Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2011, 96 (2), pp.E360-7. ⟨10.1210/jc.2010-0912⟩

International audience; CONTEXT: Sex steroids play a central role in breast cancer development. OBJECTIVE: This study aimed to relate polymorphic variants in 36 candidate genes in the sex steroid pathway to serum concentrations of sex steroid hormone

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d14a51b6ded3a3c9eca6e02ce01b54ac
https://hal.archives-ouvertes.fr/hal-00776784

Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology

Autor: Pierre Gourdy, Françoise Lenfant, Bertrand Calippe, Coralie Fontaine, Jean-François Arnal, Henrik Laurell, A Billon

Publikováno v: Climacteric
Climacteric, 2009, 12 Suppl 1, pp.12-7

International audience; Whereas hormonal therapy (HT) may increase the risk of coronary heart disease (CHD) and stroke in menopausal women, epidemiological studies (protection in premenopausal women) suggest and experimental studies (prevention of fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be646a988c81d6b4c07c5ded34de3357
https://www.hal.inserm.fr/inserm-00512765

Clinical relevance of amphiregulin and VEGF in primary breast cancers

Autor: Sylvie Romain, Sylvie Desruisseau, Pierre-Marie Martin, Corinne Giusti, Yolande Berthois, Jaqueline Palmari

Publikováno v: International Journal of Cancer
International Journal of Cancer, Wiley, 2004, 111 (5), pp.733-40. ⟨10.1002/ijc.20312⟩

The characterization of novel prognostic markers in breast cancer is necessary to improve the identification of high-risk populations. In our study, the prognostic significance of VEGF and amphiregulin (AR) was investigated and compared to convention

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::442bd3a88b78773e6d1bfadc66899d52
https://www.hal.inserm.fr/inserm-00156292/document

Understanding the controversy about hormonal replacement therapy: Insights from estrogen effects on experimental and clinical atherosclerosis

Autor: Arnal, J. -F, Douin-Echinard, V., Tremollières, F., Terrisse, A. -D, Sié, P., Payrastre, B., Guery, J. -C, Bayard, F., Pierre Gourdy

Publikováno v: Scopus-Elsevier
ResearcherID
Archives des Maladies du Coeur et des Vaisseaux
Archives des Maladies du Coeur et des Vaisseaux, 2007, 100 (6-7), pp.554-62
Archives des Maladies du Coeur et des Vaisseaux, J B Bailliere et Fils, 2007, 100 (6-7), pp.554-62
Europe PubMed Central

International audience; Whereas hormonal replacement/menopause therapy (HRT) in post-menopausal women increases the coronary artery risk, epidemiological studies (protection in pre-menopaused women) suggest and experimental studies (prevention of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f0498b196d2b61a8d3dcdac5d8d32fb4
http://www.scopus.com/inward/record.url?eid=2-s2.0-34547786780&partnerID=MN8TOARS